Oxaliplatin

• A Phase I open label followed by a Phase II randomized, controlled study to assess the efficacy and safety of ABTL0812 in combination with F… Ended
  2024-515379-36-00 Phase I/II 2 countries Ability Pharmaceuticals S.A.
• Tocotrienol and bevacizumab in metastatic colorectal cancer. A randomized phase II marker trial Ended
  2024-517075-21-00 Phase II 1 country Lillebaelt Hospital
• Short course radiotherapy versus chemoradiotherapy, followed by consolidation chemotherapy, and selective organ preservation for MRI-defined… Ended
  2024-511577-29-01 Phase III 1 country Goethe University Frankfurt
• Liposomal iRInotecan, Carboplatin or oXaliplatin in the first line treatment of esophagogastric cancer: a randomized phase 2 study (LyRICX) Ended
  2023-509287-26-00 Phase II 1 country Amsterdam UMC
• Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer Ended
  2024-512165-13-00 Phase II 1 country Unicancer
• REVOLUTION - Randomized phasE 2 study of Valproic acid in combination with bevacizumab and Oxaliplatin/fLUoropyrimidine regimens in patients… Ended
  2024-516844-25-01 Phase II 1 country IRCCS Istituto Nazionale Tumori Fondazione Pascale
• Irinotecan-based triplet (FOLFOXIRI) as perioperative treatment in resectable gastric and gastroesophageal junction adenocarcinoma - a phase… Ended
  2023-509044-96-00 Phase II 2 countries Region Skane
• Clinical trial to compare the efficacy of two treatment sequencing schemes with chemotherapy (the regime called FOLFOX and FOLFIRI) in combi… Ended
  2024-510967-41-00 Phase III 2 countries Asociacion Grupo Tratamiento De Tumores Digestivos
• DANTE / FLOT8 A randomized, open-label Phase II/III efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in … Ended
  2024-514945-12-00 Phase II/III 1 country Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
• A Phase 2 Study of Zolbetuximab (IMAB362) as Monotherapy and in Combination with Chemotherapy and/or Immunotherapy in Subjects with Metastat… Ended
  2024-511649-21-00 Phase II 2 countries Astellas Pharma Global Development Inc.
• CRITICS-II Ended
  2023-503248-15-00 Phase II 1 country Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis
• Treatment of peritoneal dissemination in stomach cancer patients with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy; P… Ended
  2023-510159-53-01 Phase II 4 countries Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
• Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer Patients (PANIRINOX) Ended
  2024-510645-34-00 Phase II 1 country Unicancer
• IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting Ended
  2024-517489-41-00 Phase III 2 countries Unicancer
• NEOadjuvant chemotherapy only compared with standard treatment for Locally Advanced Rectal cancer: a randomized phase II trial Ended
  2024-517748-76-00 Phase I/II 1 country Region Sjaelland
• PRODIGE 34 - ADAGE: Randomised phase III study evaluating adjuvant chemotherapy after resection of stage III colon adenocarcinoma in patient… Ended
  2024-518741-21-00 Phase II 2 countries Fondation Franc.Cancerologie Digestive
• Neoadjuvant chemotherapy versus standard treatment in patients with locally advanced colon cancer (NeoCol) Ended
  2024-514294-22-01 Phase III 2 countries Lillebaelt Hospital
• Neoadjuvant pembrolizumab with a watch-and-wait strategy for patients with mismatch repair-deficient or microsatellite instability-high (dMM… Halted
  2023-509322-22-00 Phase II 1 country Gercor
• IMMUNORARE5 : A national platform of 5 academic phase II trials coordinated by Lyon university hospital to assess the safety and the efficac… Halted
  2024-517254-99-00 Phase II 1 country Hospices Civils De Lyon
• NeoART – A phase Ib/II platform trial evaluating the safety and activity of neoadjuvant trastuzumab-deruxtecan containing combination therap… Halted
  2024-518841-12-00 Phase I/II 2 countries Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
• Use of circulating tumor dna test to intensify post-operative treatment of patients with resected colon cancer. Halted
  2024-515152-20-00 Phase II 1 country Gruppo Oncologico Del Nord Ovest
• Open-Label, Single Arm Phase II Trial Investigating the Efficacy, Safety and Quality of Life of Neoadjuvant Chemotherapy with Liposomal Irin… Halted
  2024-512951-18-00 Phase II 1 country University Of Cologne
• A phase I/II trial of D,L-MEthadone and mFOLFOX6 in treatment of advanced colorectal cancer (MEFOX) Ended
  2024-519509-37-00 Phase I/II 1 country AIO-Studien gGmbH
• THE (COST)EFFECTIVENESS OF NEOADJUVANT FOLFIRINOX VERSUS NEOADJUVANT GEMCITABINE BASED CHEMORADIOTHERAPY AND ADJUVANT GEMCITABINE FOR (BORDE… Ended
  2024-516260-29-00 Phase III 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Showing 169–192 of 224 trials